Karbinal Suspension, Extended Release
Product Images NDC 23594-101

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Karbinal (NDC 23594-101). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aytu Therapeutics, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image
FDA Label Image

Chemical Structure (Karbinal 01)

FDA Label Image

Chemical Structure (Karbinal 02)

FDA Label Image

Karbinal 16oz

Karbinal 16oz
This is the product information for a medication called Karbinal cr sz. It is an extended-release oral suspension medication containing carbinoxamine maleate for treating soreness and ocusors. The usual dosage information is provided in the prescribing information and it is recommended to dispense using an accurate milliliter measuring device. The medication should be kept in a light-resistant container. The medication should also be shaken well before use. The manufacturer of this product is Aytu Therapeatics. The medication is intended for use under the supervision of a qualified healthcare professional.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.